Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 18:03:06 GMT 2023
by
admin
on
Sat Dec 16 18:03:06 GMT 2023
|
| Protein Sub Type | |
| Sequence Type | COMPLETE |
| Record UNII |
IT063R5MY0
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
M05BC02
Created by
admin on Sat Dec 16 18:03:07 GMT 2023 , Edited by admin on Sat Dec 16 18:03:07 GMT 2023
|
||
|
WHO-VATC |
QM05BC02
Created by
admin on Sat Dec 16 18:03:07 GMT 2023 , Edited by admin on Sat Dec 16 18:03:07 GMT 2023
|
||
|
EMA ASSESSMENT REPORTS |
OPGENRA (AUTHORIZED: SPONDYLOLISTHESIS)
Created by
admin on Sat Dec 16 18:03:07 GMT 2023 , Edited by admin on Sat Dec 16 18:03:07 GMT 2023
|
||
|
EMA ASSESSMENT REPORTS |
OSIGRAFT (AUTHORIZED: TIBIAL FRACTURES)
Created by
admin on Sat Dec 16 18:03:07 GMT 2023 , Edited by admin on Sat Dec 16 18:03:07 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
129805-33-0
Created by
admin on Sat Dec 16 18:03:07 GMT 2023 , Edited by admin on Sat Dec 16 18:03:07 GMT 2023
|
PRIMARY | |||
|
5175
Created by
admin on Sat Dec 16 18:03:07 GMT 2023 , Edited by admin on Sat Dec 16 18:03:07 GMT 2023
|
PRIMARY | |||
|
SUB20066
Created by
admin on Sat Dec 16 18:03:07 GMT 2023 , Edited by admin on Sat Dec 16 18:03:07 GMT 2023
|
PRIMARY | |||
|
7989
Created by
admin on Sat Dec 16 18:03:07 GMT 2023 , Edited by admin on Sat Dec 16 18:03:07 GMT 2023
|
PRIMARY | |||
|
CHEMBL2108594
Created by
admin on Sat Dec 16 18:03:07 GMT 2023 , Edited by admin on Sat Dec 16 18:03:07 GMT 2023
|
PRIMARY | |||
|
D055419
Created by
admin on Sat Dec 16 18:03:07 GMT 2023 , Edited by admin on Sat Dec 16 18:03:07 GMT 2023
|
PRIMARY | |||
|
100000089545
Created by
admin on Sat Dec 16 18:03:07 GMT 2023 , Edited by admin on Sat Dec 16 18:03:07 GMT 2023
|
PRIMARY | |||
|
C170404
Created by
admin on Sat Dec 16 18:03:07 GMT 2023 , Edited by admin on Sat Dec 16 18:03:07 GMT 2023
|
PRIMARY | |||
|
IT063R5MY0
Created by
admin on Sat Dec 16 18:03:07 GMT 2023 , Edited by admin on Sat Dec 16 18:03:07 GMT 2023
|
PRIMARY | |||
|
DB11631
Created by
admin on Sat Dec 16 18:03:07 GMT 2023 , Edited by admin on Sat Dec 16 18:03:07 GMT 2023
|
PRIMARY |
| From | To |
|---|---|
| 1_38 | 1_104 |
| 1_67 | 1_136 |
| 1_71 | 1_138 |
| 1_103 | 2_103 |
| 2_38 | 2_104 |
| 2_67 | 2_136 |
| 2_71 | 2_138 |
| Glycosylation Type | MAMMALIAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_10 |
| N | 1_29 |
| N | 1_80 |
| N | 2_10 |
| N | 2_29 |
| N | 2_80 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> AGONIST |
Type I receptor ACVR1, type II receptor ACVR2A and BMP-7 agonist proteins must form a complex to initiate the canonical BMP signaling cascade.
|
||
|
TARGET -> AGONIST |
Type I receptor ACVR1, type II receptor ACVR2A and BMP-7 agonist proteins must form a complex to initiate the canonical BMP signaling cascade.
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|
||||
| Molecular Formula | CHEMICAL |
|